GILD
Gilead Sciences Inc
NASDAQ: GILD · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$130.84
+1.55% today
Updated 2026-04-30
Market cap
$159.92B
P/E ratio
19.00
P/S ratio
5.43x
EPS (TTM)
$6.78
Dividend yield
2.44%
52W range
$93 – $156
Volume
6.1M
Gilead Sciences Inc (GILD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.77B | $4.09B | $5.83B | $6.94B | $9.70B | $11.59B | $17.30B | $21.24B | $22.58B | $34.66B | $51.84B | $56.98B | $70.28B | $63.67B | $61.63B | $68.41B | $67.95B | $63.17B | $62.13B | $58.99B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $3.09B | $2.43B | $3.03B | $4.28B | $4.81B | $5.71B | $13.92B | $6.16B | $7.00B | $17.75B | $34.02B | $38.48B | $31.82B | $35.84B | $30.30B | $16.00B | $14.77B | $14.44B | $16.09B | $19.17B |
| Total liabilities | $738.54M | $2.22B | $2.23B | $2.47B | $3.19B | $5.47B | $10.44B | $11.70B | $10.83B | $18.84B | $32.73B | $37.61B | $49.78B | $42.14B | $38.98B | $50.19B | $46.89B | $41.96B | $39.38B | $39.75B |
| Current liabilities | $465.16M | $764.28M | $736.27M | $1.22B | $1.87B | $2.46B | $2.51B | $4.24B | $6.41B | $5.62B | $9.89B | $9.22B | $11.63B | $10.61B | $9.76B | $11.40B | $11.61B | $11.24B | $11.28B | $12.00B |
| Long-term debt | $240.65M | $1.38B | $1.30B | $1.30B | $1.16B | $2.84B | $7.61B | $7.05B | $3.94B | $11.92B | $21.20B | $26.35B | $30.80B | $24.57B | $22.09B | $28.64B | $25.18B | $22.96B | $23.19B | $24.90B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $809.64M | $-891.36M | $249.08M | $300.31M | $2.00B | $1.18B | $1.78B | $3.70B | $6.11B | $12.73B | $18.00B | $18.15B | $19.01B | $19.02B | $19.39B | $14.38B | $16.32B | $15.69B | $16.30B | $11.50B |
| Accounts receivable | $396.13M | $609.32M | $795.13M | $1.02B | $1.39B | $1.62B | $1.95B | $1.75B | $2.18B | $4.63B | $5.85B | $4.51B | $3.85B | $3.33B | $3.58B | $4.89B | $4.49B | $4.78B | $4.66B | $4.42B |
| Inventory | $216.90M | $564.14M | $599.97M | $927.87M | $1.05B | $1.20B | $1.39B | $1.74B | $1.70B | $1.39B | $1.96B | $1.59B | $801.00M | $814.00M | $922.00M | $1.68B | $1.62B | $1.51B | $1.79B | $1.71B |
| Goodwill | — | — | — | $123.01M | $1.52B | $532.67M | $1.00B | $1.06B | $1.17B | $1.17B | $1.17B | $1.17B | $4.16B | $4.12B | $4.12B | $8.11B | $8.33B | $8.31B | $8.31B | $8.31B |